-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q2 2024.
- Mereo BioPharma Group plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$12.3M, a 600% decline year-over-year.
- Mereo BioPharma Group plc annual Net Income (Loss) Attributable to Parent for 2023 was -$29.5M, a 30.2% increase from 2022.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)